Results 241 to 250 of about 19,163 (327)

Treatment modifiers and predictors of risperidone response in dementia: An individual participant data meta-analysis of six randomized controlled trials. [PDF]

Alzheimers Dement
Le HT, Lau ECY, Lu CY, Hilmer SN, Jeon YH, Low LF, Nguyen TA, Tan ECK.   +7 more
europepmc   +1 more source

Insights Into Pharmacist‐Led Deprescribing of Benzodiazepines and Related Drugs: A Qualitative Study With Physicians and Pharmacists

Basic &Clinical Pharmacology &Toxicology, Volume 137, Issue 4, October 2025.
ABSTRACT While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist‐led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's ...
Miro Korppas, Miia Tiihonen, Marika Buch Lund, Kirsi Kvarnström   +3 more
wiley   +1 more source

The Arousal Threshold: The "Weakest Link" in Obstructive Sleep Apnea Pathogenesis? [PDF]

Am J Respir Crit Care Med
Joosten SA, Edwards BA, Landry SA.
europepmc   +1 more source

Comparison of Remimazolam and Propofol for Sedation in Endoscopic Retrograde Cholangiopancreatography: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis

Digestive Endoscopy, Volume 37, Issue 10, Page 1054-1067, October 2025.
This systematic review and meta‐analysis of 5 randomized controlled trials (n = 965) compares the safety profile of remimazolam versus propofol for sedation during ERCP. Remimazolam was associated with a significantly lower incidence of hypoxia, hypotension, and bradycardia.
In Jung Kim, Geun Joo Choi, Hyoung‐Chul Oh, Hyun Kang   +3 more
wiley   +1 more source

Pharmacological treatment and psychiatric polypharmacy in forensic psychiatric care in Sweden.

Eur Psychiatry
Sitter TM, Virtanen S, Edberg H, Andiné P, Fernqvist A, Noland E, Hirvikoski T, Nilsson T, Chang Z.   +8 more
europepmc   +1 more source

Letter to the Editor: Limitations of the MMSE in the Diagnosis and Staging of Dementia: A Commentary. [PDF]

J Korean Med Sci
Finsterer J.
europepmc   +1 more source

Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose‐lowering drugs with machine learning—The Maastricht study

Diabetes, Obesity and Metabolism, Volume 27, Issue 10, Page 5524-5537, October 2025.
Abstract Background Despite the heterogeneity of type 2 diabetes (T2D), all patients are treated according to the same guideline. Some people have more difficulty reaching treatment goals (adequate glycaemic control) and maintaining quality of life (QoL).
Nikki C. C. Werkman, Johannes T. H. Nielen, José Tapia‐Galisteo, Francisco J. Somolinos‐Simón, Maria Elena Hernando, Junfeng Wang, Li Jiu, Wim G. Goettsch, Hans Bosma, Miranda T. Schram, Marleen M. J. van Greevenbroek, Anke Wesselius, Coen D. A. Stehouwer, Johanna H. M. Driessen, Gema Garcia‐Sáez   +14 more
wiley   +1 more source

The Use of Psychotropic Medications Before and During the COVID-19 Pandemic and Its Associated Factors. [PDF]

J Clin Med
Alsultan MM.
europepmc   +1 more source

Dreaming in patients with epilepsy: a cross‐sectional cohort study

Journal of Sleep Research, Volume 34, Issue 5, October 2025.
Dream recall frequency in patients with epilepsy is modulated by determinants shared with healthy subjects (age, nocturnal awakenings, role of the parieto‐occipital region) and by epilepsy‐related factors (seizure frequency, epileptic focus location).
Maïlis Charpentier‐Hélary, Aurélien de la Chapelle, Maxime Linard, Nathalie André‐Obadia, Sébastien Boulogne, Hélène Catenoix, Julien Jung, Sylvain Rheims, Katharina Schiller, Birgit Frauscher, Perrine Ruby, Laure Peter‐Derex   +11 more
wiley   +1 more source

Individual Sleep Problems Are Associated With an Accelerated Decline in Multiple Cognitive Functions in Older Adults

Journal of Sleep Research, Volume 34, Issue 5, October 2025.
ABSTRACT Poor sleep is a known risk factor of cognitive disorders, but the role of individual sleep problems in age‐related cognitive changes remains unclear. This study used two complementary statistical models to estimate nonlinear trajectories of decline in four domains of cognitive functioning in the age period between 55 and 100 years depending on
Dina Sarsembayeva, Marieke J. Schreuder, Martijn Huisman, Almar Kok, Maude Wagner, Ana W. Capuano, Catharina A. Hartman   +6 more
wiley   +1 more source